Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk

Objective Guidelines recommend initiating anticoagulation within 4 to 14 days after cardioembolic stroke. Data supporting this did not account for key factors potentially affecting the decision to initiate anticoagulation, such as infarct size, hemorrhagic transformation, or high‐risk features on ec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of neurology 2020-10, Vol.88 (4), p.807-816
Hauptverfasser:	Yaghi, Shadi, Trivedi, Tushar, Henninger, Nils, Giles, James, Liu, Angela, Nagy, Muhammad, Kaushal, Ashutosh, Azher, Idrees, Mac Grory, Brian, Fakhri, Hiba, Brown Espaillat, Kiersten, Asad, Syed Daniyal, Pasupuleti, Hemanth, Martin, Heather, Tan, Jose, Veerasamy, Manivannan, Liberman, Ava L., Esenwa, Charles, Cheng, Natalie, Moncrieffe, Khadean, Moeini‐Naghani, Iman, Siddu, Mithilesh, Scher, Erica, Leon Guerrero, Christopher R., Khan, Muhib, Nouh, Amre, Mistry, Eva, Keyrouz, Salah, Furie, Karen
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Brain Ischemia - epidemiology Cerebral Hemorrhage - epidemiology Clinical trials Confidence intervals Echocardiography Embolic Stroke - complications Embolic Stroke - drug therapy Embolism Female Fibrillation Health risks Hemorrhage Humans Ischemia Male Middle Aged Recurrence Retrospective Studies Risk Factors Stroke Time Factors Transient ischemic attack
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!